Developer docs
API playgroundTry for free, no card

Search company profiles

Reliva

Full company profile

uuid000m9c8

Namestring
Reliva
Websiteurl
relivacbd.com
Company typeenum
Private
Founded yearstring
-
Short descriptiontext

Reliva is a small private U.S. company based in Natick, Massachusetts that sells hemp-derived CBD products to consumers. The firm operates with 1-10 employees and distributes through its website, relivacbd.com, though product, pricing, and operational specifics are not publicly disclosed.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNatick, United States
HQ citystring
Natick
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
hemp-derived CBD products, consumer CBD wellness, CBD retail brand, hemp extracts, cannabidiol products
Industry2 codes
1CBD/Hemp Wellness & Supplements Retail
CodeCRANAHACPrimaryYes
2CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles)
CodeCRANAHAAPrimaryNo
NAICS code1 code
  • Food (Health) Supplement Retailers456191
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Consumer CBD / Hemp-Derived Wellness Products
No data
Cost components4 values
Supply Chain, Marketing or Sales, Personnel, Operations
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Reliva is engaged in delivering high-quality hemp-derived CBD products to consumers. The company markets and sells its own branded CBD line via its website relivacbd.com, targeting individual end-buyers in the consumer wellness segment. No detailed product catalog, pricing tiers, or technical specifications are disclosed in the source material.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Hemp-Derived CBD Products
CategoryConsumer CBD / Hemp-Derived Wellness Products
Description

High-quality hemp-derived CBD products sold to individual consumers through Reliva's own online channel.

No data
Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Reliva

Consumer CBD / Hemp-Derived Wellness Productsrelivacbd.com

Reliva is a small private U.S. company based in Natick, Massachusetts that sells hemp-derived CBD products to consumers. The firm operates with 1-10 employees and distributes through its website, relivacbd.com, though product, pricing, and operational specifics are not publicly disclosed.

Reliva firmographics

Firmographics
Name
Reliva
Website
https://relivacbd.com
Company type
Private
Headcount range
1–10 employees
Short description
Reliva is a small private U.S. company based in Natick, Massachusetts that sells hemp-derived CBD products to consumers. The firm operates with 1-10 employees and distributes through its website, relivacbd.com, though product, pricing, and operational specifics are not publicly disclosed.
Ownership category
akta.pro rank

Reliva industry classification

Industry
Product category
Consumer CBD / Hemp-Derived Wellness Products
NAICS
Food (Health) Supplement Retailers (456191)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
CBD/Hemp Wellness & Supplements Retail (CRANAHAC)
akta.pro secondary industry
CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles) (CRANAHAA)

Keywords

  • Hemp-derived CBD products
  • Consumer CBD wellness
  • CBD retail brand
  • Hemp extracts
  • Cannabidiol products

Where Reliva is headquartered

Location

Headquarters

HQ city
Natick
HQ country
United States
HQ region
North America

Markets served

Reliva business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Personnel, Operations

Reliva product offering

Product offering

Core offering

Reliva is engaged in delivering high-quality hemp-derived CBD products to consumers. The company markets and sells its own branded CBD line via its website relivacbd.com, targeting individual end-buyers in the consumer wellness segment. No detailed product catalog, pricing tiers, or technical specifications are disclosed in the source material.

Differentiator

Problem solved

Functional benefit

Products and services

  • Hemp-Derived CBD Products High-quality hemp-derived CBD products sold to individual consumers through Reliva's own online channel.

Companies that use Reliva

Customer profile

Ideal customer profiles1 record

Reliva technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Reliva competitors and assessment

Company assessment

Market position

Customer concentration

Reliva financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Reliva leadership team

Management profile

Number of profiles

Profiles3 records

Reliva funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Reliva M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Reliva

What does Reliva do?

Reliva is engaged in delivering high-quality hemp-derived CBD products to consumers. The company markets and sells its own branded CBD line via its website relivacbd.com, targeting individual end-buyers in the consumer wellness segment. No detailed product catalog, pricing tiers, or technical specifications are disclosed in the source material.

When was Reliva founded?

Reliva was founded in -1. It employs 1 to 10 people.

Where is Reliva based?

Reliva is headquartered in Natick, United States, in the North America region.

Does Reliva have an API?

No public API is recorded for Reliva.

What industry is Reliva in?

Reliva's product category is Consumer CBD / Hemp-Derived Wellness Products. Its primary akta.pro industry code is CRANAHAC, CBD/Hemp Wellness & Supplements Retail, with a secondary code of CRANAHAA, CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles). Its NAICS code is 456191 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireUS Cannabidiol (CBD) Market Report 2020-2024 Featuring Charlotte's Web, CV Sciences, Reliva CBD Wellness, & Elixinol Global LimitedResearchAndMarkets.com has published a market report analyzing the US Cannabidiol (CBD) industry, covering forecasts from 2020 to 2024 and the impact of COVID-19. The report profiles key market players including Charlotte's Web Holdings, CV Sciences, Reliva CBD Wellness, and Elixinol Global Limited, detailing their financials and strategies. It identifies growth drivers such as an aging population and regulatory changes, while noting challenges like lack of regulatory clarity.PR NewswireTalks of Legalization in the US Present Growth Opportunities for Cannabis CompaniesSeveral cannabis companies are making strategic moves to position themselves for potential US federal legalization of cannabis, with Virginia moving closer to recreational use following recent legislative passage. Pure Extracts Technologies signed a licensing deal with Taste-T for exclusive Canadian rights to Fireball gummies and partnered with Canada House Wellness Group for distribution. Sundial Growers made a $22 million strategic investment in Indiva, while Fire & Flower Holdings entered an agreement with American Acres Managers for US market entry options, and Aurora Cannabis acquired US-based CBD company Reliva.PR NewswireSmokers Turn to CBD as a Tobacco AlternativeKaival Brands Innovations Group is acquiring a patent for synthetic nicotine from Next Generation Labs to develop non-addictive smoking cessation products, while Aurora Cannabis completed its acquisition of CBD retailer Reliva. The article also notes that 24% of surveyed CBD users in the U.S. have used the substance to help quit smoking, highlighting a shift in consumer behavior.Benzinga51 Stocks Moving In Thursday's Mid-Day Session - Aurora Cannabis (NASDAQ:ACB)The article reports on mid-day stock market movements for 51 companies, highlighting significant gains and losses driven by corporate announcements such as partnerships, acquisitions, earnings reports, and regulatory developments. Key events include Surface Oncology's partnership with Merck & Co., Aurora Cannabis's acquisition of Reliva, and Luckin Coffee's continued decline following fraud disclosures and employee cuts.BenzingaA Peek Into The Markets: US Stock Futures Down Ahead Of Earnings, Jobless Claims Data - Aurora Cannabis (Aurora Cannabis Inc announced plans to acquire the CBD platform Reliva for $40 million in Aurora common shares. This corporate transaction is reported alongside broader market updates, including U.S. stock futures trading lower ahead of key economic data releases and earnings reports from companies such as Expedia Group and Synopsys.Benzinga8 Stocks To Watch For May 21, 2020 - Aurora Cannabis (NASDAQ:ACB), Best Buy Co (NYSE:BBY)Aurora Cannabis Inc announced plans to acquire the CBD platform Reliva for $40 million in Aurora common shares. Following the announcement, Aurora Cannabis shares jumped 39% to $17.72 in pre-market trading. Additionally, other companies such as Best Buy and NVIDIA are expected to report earnings today, which may also influence market dynamics.PR NewswireReliva Soars to #1 Spot Among CBD TopicalsReliva, a Natick, Massachusetts-based CBD company led by Miguel Martin, has become the number one-selling brand among CBD topicals according to IRI sales data. The company's CBD cream ranks #1 in overall sales while its relief stick ranks #3, outselling competitors such as Hemp Bombs, Select CBD, and CBD Medic. Reliva attributes its success to rigorous third-party testing, responsible sourcing, and compliance-focused marketing, with products available in over 18,000 retail stores including exclusive national retail distribution.